Guidance for pre-retirees planning to retire in 2028 on actions to take now for a secure future, based on current financial planning advice.
What Pre-Retirees Retiring in 2028 Should Be Doing Right Now
The Latest
Jobs report shows weaker-than-expected hiring in June
The June jobs report indicates weaker-than-expected hiring, raising questions about the economic outlook amid ongoing labor market concerns.
U.S. economy added 57,000 jobs in June, less than expected; unemployment rate at 4.2%
U.S. added 57,000 jobs in June, below expectations, with unemployment steady at 4.2%. The report signals a slowdown in job creation amid economic uncertainties.
7 Best Business Laptops for Online Creators in 2026
Discover the top business laptops for online creators in 2026. Find the perfect balance of performance, portability, and value for your needs.
The Etsy Product Angle That Makes 3D Printing More Interesting
Navigating the perfect Etsy product angle for 3D printing involves innovative, trend-driven strategies that will leave you eager to learn more.
Why Bundled Book Concepts Can Increase Lifetime Reader Value
Bundled book concepts boost your long-term value by offering curated packages that…
FCC says it will move toward 2027 auction of mid-band wireless spectrum
FCC plans to proceed with the 2027 auction of mid-band wireless spectrum, signaling future 5G expansion. Details are still being finalized.
Timur M Suleimenov: Statement – base rate of the National Bank of Kazakhstan
Timur Suleimenov, head of Kazakhstan’s National Bank, announced the new base rate, signaling monetary policy adjustments amid economic shifts.
Lifted’s Highlandia THC Beverage Becomes a Top-Five Seller in WI, and Plans Expansion Into Other States
Lifted’s Highlandia THC beverage has become a top-five seller in Wisconsin and plans expansion into other states, according to company and industry reports.
Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
Partner Therapeutics announces publication of eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma, highlighting potential treatment implications.
